Why Acceleron Pharma Stock Is Trading Higher Today

Acceleron Pharma XLRN shares are trading higher after Bloomberg reported the company is in talks for a potential $11 billion buyout.

According to people familiar with the matter, Acceleron could be acquired by a large pharmaceutical company for about $180 a share in cash, Bloomberg reported. However, Bloomberg was unable to identify any bidders in the deal.

Acceleron Pharma is a biotechnology company focused on the discovery, development, and commercialization of novel therapies. The company's research focuses on key natural regulators of cellular growth and repair. 

At last check, Acceleron Pharma was trading 5.57% higher at $176.98 per share.

The stock has a 52-week high of $174.23 and a 52-week low of $99.98.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Newswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!